CDK7 inhibitors as anticancer drugs
2020 · Cancer and Metastasis Reviews · 194 citations
https://doi.org/10.1007/s10555-020-09885-8
L
Lakjaya Buluwela
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
2.1K
Citations
22
h-index
24
i10-index
Lakjaya Buluwela is an academic researcher from Hammersmith Hospital. The author has contributed to research in topics: Estrogen and related hormone effects & Monoclonal and Polyclonal Antibodies Research & Liver physiology and pathology. The author has an h-index of 22, co-authored 30 publications.
Papers by this author
worksGenome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer
2022 · Oncogene · 41 citations
https://doi.org/10.1038/s41388-022-02483-8
ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942
2019 · Oncogene · 25 citations
https://doi.org/10.1038/s41388-019-1008-y
Genome Engineering For Estrogen Receptor Mutations Reveals Differential Responses To Anti-Estrogens And New Prognostic Gene Signatures For Breast Cancer
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21132874
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat